ART Medical

About

Offices

Q&A

What is ART Medical's primary focus?

ART Medical develops sensor-based medical technologies for critical care nutrition management, aiming to reduce hospital-acquired complications and improve patient outcomes.

When was ART Medical founded?

ART Medical was founded in 2008.

What is ART Medical's current employee count?

ART Medical has 51–200 employees.

How much total funding has ART Medical raised to date?

ART Medical has raised a total of $82.3 million USD.

When did ART Medical complete its most recent funding round?

ART Medical completed a D Round in August 2024, raising $20.5 million USD.

Which investors participated in ART Medical's Seed round?

ART Medical's Seed round in January 2012 included investments from Israel Innovation Authority.

What was the amount of ART Medical's Series B funding round and who were the lead investors?

ART Medical raised $20 million USD in its Series B round in June 2017, with Advanced Medical Technologies LLC as a lead investor.

What was the amount of ART Medical's Series C funding round?

ART Medical raised $32.8 million USD in its Series C round in January 2022.

What is ART Medical's current product stage?

ART Medical's product is currently in the clinical trial stage.

Has ART Medical received FDA approval for its technology?

Yes, ART Medical's technology has received FDA approval.

Team · 9

Liron Elia

Founder · Executive Director of Technology

Ori Braun

CEO

Dr. Gavriel J. (Gabi) Iddan

Chief Technology Officer

Nirit Barnea

Site Manager & VP HR

Nimrod Kadim

VP R&D

Yossi Hatan

VP Finance

Shirly Steinlauf

VP RA, QA and CA

Miri Nachlai

VP Operations

Prof. Eitan Scapa, MD

Chief Medical Officer

Sectors & technology

Highlights

Tags